You are here

  • Home
  • Archive
  • Volume 79, Issue Suppl 1
  • THU0195 INCIDENCE AND RISK OF VENOUS THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN THE UPADACITINIB SELECT CLINICAL TRIAL PROGRAM

Article info

Article menu

Download PDFPDF

Scientific Abstracts
Poster Presentations
Thursday, 04 June 2020
Rheumatoid arthritis - non biologic treatment and small molecules
THU0195 INCIDENCE AND RISK OF VENOUS THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN THE UPADACITINIB SELECT CLINICAL TRIAL PROGRAM
Free

Authors

Citation

Choy E, Mcinnes I, Cush J, et al
THU0195 INCIDENCE AND RISK OF VENOUS THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN THE UPADACITINIB SELECT CLINICAL TRIAL PROGRAM
Annals of the Rheumatic Diseases 2020;79:317-318.

Publication history

  • First published June 2, 2020.
Online issue publication 
June 02, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.